Compare AbCellera Biologics Inc (ABCL) vs Omnicom Group Inc. (OMC) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
AbCellera Biologics Inc vs Omnicom Group Inc. — how do they compare? AbCellera Biologics Inc trades at $7.1 (market cap $2.35B), while Omnicom Group Inc. trades at $78.61 (market cap $23.04B). The key difference: Omnicom Group Inc. is far larger — about 9.8× AbCellera Biologics Inc's market cap, and Omnicom Group Inc. pays a 3.96% dividend while AbCellera Biologics Inc pays none. Which is the better fit depends on your goals.
| ABCL | OMC | |
|---|---|---|
Market Cap | $2.35B | $23.04B |
Sector | Health | Media |
52-Week High | $8.12 | $85.80 |
52-Week Low | $2.78 | $67.27 |
Enterprise Value | $1.99B | $30.27B |
Dividend Yield | — | 3.96% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About AbCellera Biologics Inc
AbCellera Biologics Inc is a biotechnology company. It develops antibodies to treat infectious diseases and various other types of diseases. The company's AI-powered technology sources, searches, decodes and analyzes antibody responses to engineer new antibody drug candidates for its partners.
Read more on ABCL →About Omnicom Group Inc.
Omnicom is the world's second- largest ad holding company, based on annual revenue. The firm's services, which include traditional and digital advertising and public relations, are provided worldwide, with over 85% of its revenue coming from more developed regions such as North America and Europe.
Read more on OMC →
